• Updated

HOUSTON, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) announced that Stephanie Lundquist was elected to the company’s board of directors today at its Annual Meeting of Stockholders, expanding the size of the board to 13 members. The election of Ms. Lundquist represents the …

WALTHAM, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Hoeiland, President and CEO of the Company, will present a corporate update at the Jefferies 2019 Global Healthcare Conference in London, United Kingdom on Wednesday, November 20…

  • Updated

TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), has priced an offering of $400.0 million in aggregate principal amount of 5.125% senio…

The Eastern Idaho Business Report: Keeping local businesses connected to each other and the community.

BURNABY, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer, will participate in the following investor conferences and present a co…

  • Updated

MALVERN, Pa. and SAN DIEGO, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that Chief Executi…

  • Updated

MIAMI, FL, Nov. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. ( OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report financial results for the third quarter ended September 30, 2019.

  • Updated

TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), intends to offer, subject to market and other conditions, up to $400.0 million in aggr…

  • Updated

CAMBRIDGE, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, today announced its participation in the following upcoming investor conference:

RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 3:20 p.m. GMT in Aldwych, London, UK.

  • Updated

BEIJING, Nov. 15, 2019 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD), China’s leading technology driven e-commerce company and retail infrastructure service provider, today announced its unaudited financial results for the quarter ended September 30, 2019.

  • Updated

BEIJING, Nov. 15, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services in China, today announced that it will report its financial results for …

  • Updated

CAMBRIDGE, Mass., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the St…

HOUSTON, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the board of directors has approved a 15 percent increase in the quarterly cash dividend to $0.45 per share from the current $0.39 per share. The new dividend is payable on Jan. 24, 2020, to common s…

  • Updated

PRINCETON, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Applicat…

  • Updated

SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the Jefferies 2019 London Healthcare Conference in London, UK on Thursday, November 21, 2019 at 12:40 p.m. GMT (7:40 a.m. ET).

WILMINGTON, Del., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI), a leading education loan management and business processing solutions company, today announced that its board of directors approved a 2019 fourth quarter dividend of $0.16 per share on the company's common stock.

Newport Beach, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report on Form 10-Q announcing its financial results for the periods ended September…

  • Updated

-- Fourth quarter net revenues of $129.6 million compared to net revenues of $122.3 million for the same period of fiscal 2018. Fiscal year 2019 net revenues of $490.2 million compared to net revenues of $435.3 million for fiscal 2018. -- Fourth quarter net income of $6.0 million, or $0.48 p…

SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that Scott Wolchko, President and Chief Executi…